Nathalie J A Teeuwen-Dedroog

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

M. Pepels, V. Tjan-Heijnen, F. Erdkamp, 2023, Breast Cancer Research and Treatment.